This study evaluated the efficacy and safety of tranexamic acid (TXA) in reducing intraoperative bleeding during Mohs micrographic surgery. TXA administration was associated with reduced bleeding and improved visualization without significant adverse events, supporting its use as an adjunct hemostatic agent.

Tranexamic acid can effectively reduce intraoperative bleeding during Mohs surgery without significant safety concerns.

TXA may be particularly beneficial in patients on anticoagulation or in vascular anatomic sites prone to excessive bleeding.